171 related articles for article (PubMed ID: 19496736)
1. Diagnostic performance of the ARCHITECT C-Peptide immunoassay.
Schultess J; van Duren C; Martens M; Costa M; Llop T; Martí T; Eppinger M; Hausmann M; Krack W; Dhein J
Clin Chem Lab Med; 2009; 47(7):834-41. PubMed ID: 19496736
[TBL] [Abstract][Full Text] [Related]
2. Automated chemiluminescent assay for C-peptide.
Hardy RW; Cohn M; Konrad RJ
J Clin Lab Anal; 2000; 14(1):17-9. PubMed ID: 10645980
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of immunochemiluminometric assays for the measurement of insulin and C-peptide using the ADVIA Centaur.
El Kenz H; Bergmann P
Clin Lab; 2004; 50(3-4):171-4. PubMed ID: 15074471
[TBL] [Abstract][Full Text] [Related]
4. Performance of hepatitis B assays on the Bayer ADVIA Centaur Immunoassay System.
van Helden J; Denoyel G; Karwowska S; Reamer R; Schmalz J; Wright T; Preisel-Simmons B
Clin Lab; 2004; 50(1-2):63-73. PubMed ID: 15000222
[TBL] [Abstract][Full Text] [Related]
5. Performance evaluation and cross-reactivity from insulin analogs with the ARCHITECT insulin assay.
Moriyama M; Hayashi N; Ohyabu C; Mukai M; Kawano S; Kumagai S
Clin Chem; 2006 Jul; 52(7):1423-6. PubMed ID: 16690737
[TBL] [Abstract][Full Text] [Related]
6. Performance characteristics of the Architect brain natriuretic peptide (BNP) assay: a two site study.
Mongia SK; La'ulu SL; Apple FS; Ler R; Murakami MM; Roberts WL
Clin Chim Acta; 2008 May; 391(1-2):102-5. PubMed ID: 18294456
[TBL] [Abstract][Full Text] [Related]
7. Improvement and multicenter evaluation of the analytical performance of an automated chemiluminescent immunoassay for alpha fetoprotein.
Morota K; Komori M; Fujinami R; Yamada K; Kuribayashi K; Watanabe N; Sokoll LJ; Elliott D; Chan DW; Martens F; Heijboer AC; Blankenstein MA; Hershberger SJ; Pfeiffer ZA; Vaidya SV; Dowell BL
Int J Biol Markers; 2012; 27(1):39-46. PubMed ID: 22020369
[TBL] [Abstract][Full Text] [Related]
8. Laboratory and Clinical Performance of the ADVIA Centaur Anticyclic Citrullinated Peptide Assay for Rheumatoid Arthritis Diagnosis.
Kim B; Park Y; Park JS; Jang KJ; Ahn HJ; Choi MH; Lee CH
Arch Pathol Lab Med; 2018 Dec; 142(12):1554-1559. PubMed ID: 29949389
[TBL] [Abstract][Full Text] [Related]
9. Development and analytical performance evaluation of an automated chemiluminescent immunoassay for pro-gastrin releasing peptide (ProGRP).
Yoshimura T; Fujita K; Kinukawa H; Matsuoka Y; Patil RD; Beligere GS; Chan SS; Dowell BL; Sokoll L; Elliott D; Chan DW; Scheuer C; Hofmann K; Stieber P; Sakurai Y; Iizuka M; Saegusa H; Yamaguchi K
Clin Chem Lab Med; 2009; 47(12):1557-63. PubMed ID: 19824798
[TBL] [Abstract][Full Text] [Related]
10. Performance of a new hepatitis C assay on the Bayer ADVIA Centaur Immunoassay System.
Denoyel G; van Helden J; Bauer R; Preisel-Simmons B
Clin Lab; 2004; 50(1-2):75-82. PubMed ID: 15000223
[TBL] [Abstract][Full Text] [Related]
11. Clinical Utility and Cross-Reactivity of Insulin and C-Peptide Assays by the Lumipulse G1200 System.
Oh J; Kim JH; Park HD
Ann Lab Med; 2018 Nov; 38(6):530-537. PubMed ID: 30027696
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of analytical performance of a fully automated chemiluminescent immunoassay for protein induced by vitamin K absence or antagonist II.
Fujita K; Kinukawa H; Ohno K; Ito Y; Saegusa H; Yoshimura T
Clin Biochem; 2015 Dec; 48(18):1330-6. PubMed ID: 26210849
[TBL] [Abstract][Full Text] [Related]
13. Analytical performance of a new two-step ADVIA Centaur estradiol immunoassay during ovarian stimulation.
Massart C; Gibassier J; Laurent MC; Le Lannou DL
Clin Chem Lab Med; 2006; 44(1):105-9. PubMed ID: 16375595
[TBL] [Abstract][Full Text] [Related]
14. European performance evaluations of the ADVIA Centaur infectious disease assays: requirements for performance evaluation according to the European directive on in vitro diagnostics.
Dati F; Denoyel G; van Helden J
J Clin Virol; 2004 Apr; 30 Suppl 1():S6-10. PubMed ID: 15062761
[TBL] [Abstract][Full Text] [Related]
15. Performance evaluation of a specific IgE assay developed for the ADVIA centaur immunoassay system.
Petersen AB; Gudmann P; Milvang-Grønager P; Mørkeberg R; Bøgestrand S; Linneberg A; Johansen N
Clin Biochem; 2004 Oct; 37(10):882-92. PubMed ID: 15369719
[TBL] [Abstract][Full Text] [Related]
16. Performance of a new HIV 1/O/2 assay on the Bayer ADVIA Centaur immunoassay system.
van Helden J; Denoyel G; Freeman J; Preisel-Simmons B
Clin Lab; 2004; 50(1-2):83-90. PubMed ID: 15000224
[TBL] [Abstract][Full Text] [Related]
17. A comparison of different sample matrices for evaluating functional sensitivity, imprecision and dilution linearity of the Abbott ARCHITECT i2000 TSH assay.
Quinn FA; Scopp R; Lach A; Drake C; Mo M; Albright J; Trimpe K
Clin Chem Lab Med; 2002 Jul; 40(7):709-12. PubMed ID: 12241019
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of commercial ELISA and RIA for measuring porcine C-peptide: implications for research.
Graham ML; Gresch SC; Hardy SK; Mutch LA; Janecek JL; Hegstad-Davies RL
Xenotransplantation; 2015; 22(1):62-9. PubMed ID: 25291621
[TBL] [Abstract][Full Text] [Related]
19. Mass spectrometric and physiological validation of a sensitive, automated, direct immunoassay for serum estradiol using the Architect.
Sluss PM; Hayes FJ; Adams JM; Barnes W; Williams G; Frost S; Ramp J; Pacenti D; Lehotay DC; George S; Ramsay C; Doss RC; Crowley WF
Clin Chim Acta; 2008 Feb; 388(1-2):99-105. PubMed ID: 18023274
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the analytical performance characteristics of the Bayer ACS:180 B-type natriuretic peptide (BNP) assay.
Wians FH; Wilson BA; Grant A; Bailey J; Gheorghiu I; Conarpe C; Mindicino H; Thakur K; Belenky A; Despres N; Bluestein B
Clin Chim Acta; 2005 Mar; 353(1-2):147-55. PubMed ID: 15698602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
